Clinical Trial Update: KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial [Phase 1]

View source ↗

Summary

Phase 1 exploratory trial evaluating KSD-101 therapy for Epstein-Barr virus-associated hematologic malignancies, currently enrolling by invitation at Tongji Hos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epstein-barr Virus-associated Hematologic Malignancies

Drugs mentioned

• KSD-101

Snippet

Sponsor: Tongji Hospital | Conditions: EBV-associated Haematologic Neoplasms | Phase 1 | Status: ENROLLING_BY_INVITATION